The Impact of High-Risk Procedures on Medspa Premiums
While most medspa services can be insured, certain procedures draw heavy scrutiny from carriers, leading to premium increases or outright exclusions.
| Procedure Category |
Examples |
Why It's Higher Risk |
Insurance Impact |
| Injectables |
Botox, dermal fillers |
Frequent claims for asymmetry, allergic reactions, or vascular occlusion |
20–30% premium increase; denial possible if staff are unqualified |
| Laser & Energy-Based Treatments |
Laser hair removal, skin resurfacing, IPL |
Burns, pigmentation issues, and eye injuries if not performed correctly |
Up to 50% premium increase; some carriers require endorsements |
| Regenerative & Biologic Therapies |
PRP injections, stem cell therapy |
Experimental nature; FDA scrutiny; infection or inefficacy claims |
Often excluded; premiums can double if offered |
| Hormone & Weight Loss Therapies |
Hormone replacement, semaglutide injections |
Cardiovascular side effects, dosing errors |
30%+ increase; refusal if not under physician oversight |
| Invasive Body Contouring |
Butt lifts with fillers, non-surgical fat reduction |
Frequent complications; often off-label or experimental |
Coverage often refused; six-figure lawsuit exposure |
| Anti-Aging & Skin Procedures |
Chemical peels, microneedling with RF |
Complications from deeper peels or combined treatments |
Moderate premium increases; strong consent documentation required |
Compounded Weight-Loss Drugs: What Every Medspa Should Know
With rising demand for GLP-1 medications like Ozempic and Mounjaro, some medspas are turning to compounded or generic versions to cut costs. But using non-FDA-approved compounds for weight loss can put your business at serious risk. Many insurance policies specifically exclude coverage for compounded medications — and one mistake could leave you without protection when you need it most.
If your medspa is offering weight-loss injections, make sure your coverage isn't at risk. Here's what you need to know:
- Compounded GLP-1s are not FDA-approved and often contain unverified chemical forms like semaglutide sodium or acetate.
- Use of non-approved drugs may void your insurance — including malpractice and general liability policies.
- The FDA has banned compounded versions of these drugs unless there is a verified shortage.
- Patients have reported overdoses, hospitalizations, and adverse reactions from compounded formulations.
- We recommend sticking with FDA-approved medications only and disclosing all treatments to your broker.
⬆ Back to contents